Posted by Michael Wonder on 07 Jan 2025
ICER to assess treatments for spinal muscular atrophy
6 January 2025 - Report will be subject of Midwest CEPAC meeting in August 2025; draft scoping document open to public comment until 27 January 2025.
The ICER announced today that it will assess the comparative clinical effectiveness and value of apitegromab (Scholar Rock) for the treatment of spinal muscular atrophy.
